Stereotaxis Logo - New Tagline - Black Text.png
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
December 09, 2024 07:25 ET | Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™ Magnetic...
Transparency Market Research
Microwave Ablation Devices Market to Surpass $1 Billion by 2034 Driven by Advances in Cancer Treatment | Transparency Market Research, Inc.
December 06, 2024 06:55 ET | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc.-, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Microwave ablation (MWA) technology represents a groundbreaking approach to tumor...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
December 02, 2024 08:45 ET | Stereotaxis, Inc.
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’ latest...
Dr. Nishant Sharma (left) and Dr. Corey Adams (right)
Minimally invasive intervention program set to revolutionize open-heart surgery in Alberta
November 28, 2024 12:08 ET | Calgary Health Foundation
Calgary, Alberta, Canada, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Calgary Health Foundation announces a $3.52M commitment toward the establishment of an innovative heart valve intervention program at...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
November 25, 2024 08:21 ET | Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced regulatory approval of the...
Stereotaxis Logo - New Tagline - Black Text.png
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
November 20, 2024 08:18 ET | Stereotaxis, Inc.
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
PMV main logo.png
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024 08:00 ET | PRISM MarketView
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
Stereotaxis Logo - New Tagline - Black Text.png
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
November 06, 2024 08:25 ET | Stereotaxis, Inc.
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
October 27, 2024 08:15 ET | HeartFlow Holding, Inc.
— Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease -– FFRCT further...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
October 21, 2024 08:41 ET | Stereotaxis, Inc.
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...